Ikena Oncology has been granted a patent for compounds and methods for treating cancer. The invention includes specific compounds and compositions for treating cancer in patients. GlobalData’s report on Ikena Oncology gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Ikena Oncology, Cancer treatment biomarkers was a key innovation area identified from patents. Ikena Oncology's grant share as of April 2024 was 10%. Grant share is based on the ratio of number of grants to total number of patents.
Cancer treatment method using compounds of formula i
A recently granted patent (Publication Number: US11925651B2) discloses a method for treating cancer in a patient by administering a compound of Formula I'. The method involves specific criteria for the compound, including the structure of L1, Ring A, Ring B, and Rw, as well as the selection of the compound from various formulas such as (IX), (X), (XII), (XIII), (XIV), and (XV). The patent also specifies the association of the cancer with increased TEAD expression or activity, particularly TEAD1, TEAD2, TEAD3, and TEAD4, as well as the localization of YAP in the nucleus of cancer cells.
Furthermore, the patent outlines the types of cancers that can be treated using this method, including lung cancer, thyroid cancer, ovarian cancer, colorectal cancer, prostate cancer, pancreatic cancer, esophageal cancer, liver cancer, breast cancer, skin cancer, mesothelioma, and leukemia. The method involves the administration of the compound to target cancer cells with specific characteristics related to TEAD expression and YAP localization. The patent provides a detailed description of the chemical structure of the compound and its mode of action in treating cancer, offering a novel approach to cancer therapy based on targeting specific molecular pathways involved in cancer progression.
To know more about GlobalData’s detailed insights on Ikena Oncology, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
